Enlightenment Research’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,300
| Closed | -$314K | – | 132 |
|
|
2021
Q3 | $314K | Buy |
+5,300
| New | +$314K | 0.38% | 97 |
|
|
2021
Q2 | – | Sell |
-11,400
| Closed | -$720K | – | 141 |
|
|
2021
Q1 | $720K | Buy |
11,400
+6,600
| +138% | +$417K | 0.86% | 31 |
|
|
2020
Q4 | $298K | Buy |
+4,800
| New | +$298K | 0.42% | 60 |
|
|
2020
Q2 | – | Sell |
-15,100
| Closed | -$892K | – | 103 |
|
|
2020
Q1 | $892K | Buy |
15,100
+6,700
| +80% | +$396K | 0.95% | 17 |
|
|
2019
Q4 | $539K | Sell |
8,400
-2,300
| -21% | -$148K | 2.52% | 10 |
|
|
2019
Q3 | $543K | Buy |
+10,700
| New | +$543K | 1.2% | 24 |
|
|
2019
Q2 | – | Sell |
-25,800
| Closed | -$1.23M | – | 272 |
|
|
2019
Q1 | $1.23M | Buy |
+25,800
| New | +$1.23M | 2.4% | 9 |
|